# Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis

> **NCT06105060** · EARLY_PHASE1 · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 175 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis

## Interventions

- **DRUG:** Rosuvastatin 20mg

## Key facts

- **NCT ID:** NCT06105060
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-17
- **Primary completion:** 2024-06-17
- **Final completion:** 2024-06-27
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06105060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06105060, "Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06105060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*